Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: lipitor attending: chief complaint: congestive heart failure major surgical or invasive procedure: ultrafiltration by chf solutions, removal of approximately 13 liters of fluid history of present illness: this is a 58 year old man wiuth a history of chf, dm, and hypertension who was electively admitted for subacute chf exacerbation and ultrafiltration. he reports a 20 pound weight gain over the last 1-2 months, increasing le edema, and increasing sob so that he can barely conduct adl's. he denies fever, abd pain, dysuria. past medical history: chf (ef of 50% by echo on ) ddd pacemaker for sick sinus node in afib, paroxysmal type ii diabetes mellitus pulmonary sarcoid, diagnosed htn hypercholesterolemia ldl 106 cri (baseline cr of 2.7) hypothyroidism s/p excision of thyroid nodule osa, on bipap s/p cervical spine surgery history of elevated ck's left hallux ulcer mgus raynaud's chronic sensorimotor neuropathy social history: prior stock broker, out of work since icu admission in married with two children denies tobacco, alcohol, drugs family history: father with history of diabetes, diagnosed age 75 mother with valve surgery at age 70 brother with history of spinal stenosis physical exam: v: 96.7 bp 157/83 r22 hr 60 o2 90% ra gen: sitting in bed, speaking in full sentences heent: perrl, mmm, op clear neck: jvp >15 cm resp: cta bilaterally except scattered crackles r base cv: rrr nl s1s2 no m abd: soft, obese, ntnd ext: 3+ edema to legs, small 1 cm open ulcers on shins pertinent results: 137 101 85 / ------------- 135 4.4 25 4.0 \ ca: 9.1 mg: 2.6 p: 5.3 alt: 31 ap: 50 tbili: 0.6 alb: 4.4 ast: 48 ldh: 247 \ 9.3 / 8.8 ----- 299 / 28.2 \ cxr: findings: a right subclavian line is in place, with tip crossing the midline and terminating in the left upper mediastinum. a left-sided pacemaker is in unchanged position, with dual electrodes. the electrode leads also course to the left of the mediastinum. these findings are suggestive of a left-sided svc. the heart size and mediastinal contours are unchanged, with mild cardiomegaly. there is bibasilar atelectasis and a small right pleural effusion. the left costophrenic angle is excluded from the radiograph. minimal haziness of the interstitial markings, consistent with mild congestive heart failure. the osseous structures appear unchanged. no pneumothorax. impression 1. right subclavian venous access catheter with tip terminating in the upper portion of a left-sided svc. no pneumothorax. 2. mild cardiomegaly and mild congestive heart failure, slightly improved. small right pleural effusion. 3. bibasilar atelectasis. ekg: sinus rhythm. first degree a-v delay. left atrial abnormality. left bundle-branch block. since the previous tracing of atrial pacing is not evident. brief hospital course: 1. chf: the patient was admitted electively for ultrafiltration as he was chronically total body overloaded with fluid. approximately 13 liters of fluid were removed with the chf solutions ultrafiltration machine over the course of 2 days. his diuretics were held but toprol was continued. he was not on an ace due to renal dysfunction. 2. htn: the patient was hypertensive while hospitalized. he was on two separate dihydropyridine calcium channel blockers as an outpatient. both of these were discontinued, and hydralazine was started instead as an afterload reducing since an ace was contraindicated. 3. cri: worsening over last months. his creatinine worsensed from 3.6 at admission to 4.3 at discharge. renal service was consulted, who recommended close follow up and possible dialysis. 4. dmii: patient was on a sliding scale involving 70/30 insulin sliding scale in the morning and nph sliding scale in the evening. this was continued along with his prandin. 5. anemia: the patient had chronic anemia likely cri. he is on outpatient epogen at home. his hemoglobin was stable. 6. peripheral neuropathy: his amitriptyline and neurontin were continued. 7. raynauds: his nifedipine was discontinued due to possible exacerbation of chf from nifedipine. medications on admission: 1. calcitriol 0.25 mcg capsule sig: one (1) capsule po 3x/week (mo,we,fr). 2. metoprolol succinate 100 mg tablet sustained release 24hr sig: two (2) tablet sustained release 24hr po qd (once a day). 3. ezetimibe 10 mg tablet sig: one (1) tablet po qd (once a day). 4. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po qd (once a day). 5. gabapentin 400 mg capsule sig: two (2) capsule po tid (3 times a day). 6. nortriptyline hcl 25 mg capsule sig: three (3) capsule po hs (at bedtime). 7. levothyroxine sodium 100 mcg tablet sig: one (1) tablet po qd (once a day). 8. fenofibrate micronized 160 mg tablet sig: one (1) tablet po qd (). 9. prandin 2 mg tablet sig: two (2) tablet po three times a day. 10. insulin regular human 100 unit/ml solution sig: as directed injection asdir (as directed). 11. folplex 2.2 2.2-25-0.5 mg tablet sig: one (1) tablet po qd (). 12. norvasc 13. nifedipine discharge medications: 1. calcitriol 0.25 mcg capsule sig: one (1) capsule po 3x/week (mo,we,fr). 2. metoprolol succinate 100 mg tablet sustained release 24hr sig: two (2) tablet sustained release 24hr po qd (once a day). 3. ezetimibe 10 mg tablet sig: one (1) tablet po qd (once a day). 4. aspirin 325 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po qd (once a day). 5. gabapentin 400 mg capsule sig: two (2) capsule po tid (3 times a day). 6. nortriptyline hcl 25 mg capsule sig: three (3) capsule po hs (at bedtime). 7. levothyroxine sodium 100 mcg tablet sig: one (1) tablet po qd (once a day). 8. fenofibrate micronized 160 mg tablet sig: one (1) tablet po qd (). 9. prandin 2 mg tablet sig: two (2) tablet po three times a day. 10. insulin regular human 100 unit/ml solution sig: as directed injection asdir (as directed). 11. hydralazine hcl 10 mg tablet sig: one (1) tablet po q6h (every 6 hours). disp:*120 tablet(s)* refills:*2* 12. folplex 2.2 2.2-25-0.5 mg tablet sig: one (1) tablet po qd (). discharge disposition: home discharge diagnosis: congestive heart failure acute on chronic renal failure raynaud's syndrome hypothyroidism diabetes mellitus peripheral neuropathy discharge condition: pt was ambulating, eating, having bm and feeling much better than at admission. he was eager to go home. discharge instructions: weigh yourself every morning, md if weight > 3 lbs. adhere to 2 gm sodium diet fluid restriction: 1000 ml mild activity as tolerated. please take all of your medications with the following changes: your bumex, norvasc, and nifedical have been discontinued. hydralazine has been added to control your blood pressure, if you get a rash from this medication please stop it immediately and call your pcp. followup instructions: follow up with dr. and the heart failure clinic in the next week. they will contact you for follow up. follow up with dr. from nephrology within 1 week (. follow up with dr. , d. as needed. you already have these scheduled appointments: provider: ,nine day care 8 where: day care 8 date/time: 8:00 provider: , md where: phone: date/time: 4:00 provider: , m.d. where: phone: date/time: 11:40 md procedure: venous catheterization, not elsewhere classified non-invasive mechanical ventilation aquapheresis diagnoses: anemia in chronic kidney disease pure hypercholesterolemia congestive heart failure, unspecified acute kidney failure, unspecified diabetes with neurological manifestations, type ii or unspecified type, not stated as uncontrolled polyneuropathy in diabetes sarcoidosis pulmonary collapse hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage v or end stage renal disease long-term (current) use of insulin diastolic heart failure, unspecified raynaud's syndrome lung involvement in other diseases classified elsewhere postsurgical hypothyroidism 

Answer: The patient is high likely exposed to